News

Abbott has secured U.S. Food and Drug Administration (FDA) approval for its CardioMEMS HERO device, a next-generation pulmonary artery (PA) pressure reader for heart failure patients.

The updated reader is 60% smaller and offers built-in WiFi connectivity. It works with an implantable sensor to monitor a patient's PA pressure. 

When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater. 

STS plans on using new research out of Mayo Clinic to help with the development of a surgical risk calculator for adults with this challenging condition.

Image of the A-FLUX Reducer System for chest pain by VahatiCor

The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.

Newer imaging technologies designed to use less radiation have made a considerable impact. In parts of the world where those systems have not yet been implemented, however, radiation dose levels remain quite high. 

artificial intelligence money robot dollar AI

ACR recently voiced its frustrations to Health and Human Services, sharing suggestions for how the agency could spur greater use of this technology. 

money gavel court lawsuit legal judge judgement

Thomas McNalley previously sued Toledo Radiological Associates and Vincent Keiser, MD, alleging the physician failed to diagnose a blood clot in his abdomen. 

DeepHealth, RadNet's technology subsidiary, believes the product can help to address imaging workforce challenges plaguing the EU, similar to the States.

Thumbnail

The recall has been designated as the most serious, Class I, but the issue can be remedied with a software update. The affected devices are Ivenix Large Volume Pumps manufactured by Fresenius Kabi.

The treatment addresses cancers that express Nectin-4, a protein found in excess of 80% to 90% of urothelial cancer patients.

New research is sounding the alarm on the amount of radiation patients undergoing cardiac imaging are exposed to, prompting experts to call for updated protocols. 

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Recurrent strokes and TIAs were rare, though bleeding events among women did stand out as a trend to watch going forward.

Around the web

The updated reader is 60% smaller and offers built-in WiFi connectivity. It works with an implantable sensor to monitor a patient's PA pressure.